Boeringer Ingelheim Ltd and IBM Canada plan to explore the use of blockchain technology in clinical trials. This marks the first time that blockchain technology will be used in a clinical trial setting in Canada. The alliance aims to improve the quality of clinical trial processes and record keeping. (Contract Pharma)